Estrogen activates protein kinase C in neurons: Role in neuroprotection

Journal of Neurochemistry

Volumn 84, Issue 6, 2003, Pages 1340-1348

  Cordey, Myriam ^a,c   Gundimeda, Usha ^b   Gopalakrishna, Rayudu ^b   Pike, Christian J ^a,c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

amyloid; Alzheimer's disease; Estrogen; Neuroprotection; Phorbol ester; Protein kinase C

Indexed keywords

AMYLOID BETA PROTEIN; ESTRADIOL; ESTROGEN; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR;

AGING; ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; BRAIN CELL; CONTROLLED STUDY; CYTOTOXICITY; DEGENERATIVE DISEASE; ENZYME ACTIVATION; MOUSE; NERVE CELL; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL;

AMYLOID BETA-PROTEIN; ANIMALS; CELL SURVIVAL; CELLS, CULTURED; CYTOPROTECTION; ENZYME ACTIVATION; ENZYME ACTIVATORS; ENZYME INHIBITORS; ESTRADIOL; ESTROGENS; GENE EXPRESSION REGULATION; NEURONS; NEUROPROTECTIVE AGENTS; PEPTIDE FRAGMENTS; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; TETRADECANOYLPHORBOL ACETATE;

ANIMALIA;

EID: 0037345781     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.01631.x     Document Type: Article

References (68)

1. Ansonoff M. A. and Etgen A. M. (1998) Estradiol elevates protein kinase C catalytic activity in the preoptic area of female rats. Endocrinology 139, 3050-3056.
2. Behl C., Widmann M., Trapp T. and Holsboer F. (1995) 17-beta estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem. Biophys. Res. Commun. 216, 473-482.
3. Behrens M. M., Strasser U., Koh J. Y., Gwag B. J. and Choi D. W. (1999) Prevention of neuronal apoptosis by phorbol ester-induced activation of protein kinase C: blockade of p38 mitogen-activated protein kinase. Neuroscience 94, 917-927.
4. Bradford M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
5. Cho H. and Katzenellenbogen B. S. (1993) Synergistic activation of estrogen receptor-mediated transcription by estradiol and protein kinase activators. Mol. Endocrinol. 7, 441-452.
6. Datta R., Kojima H., Yoshida K. and Kufe D. (1997) Caspase-3-mediated cleavage of protein kinase C theta in induction of apoptosis. J. Biol. Chem. 272, 20317-20320.
7. Deacon E. M., Pongracz J., Griffiths G. and Lord J. M. (1997) Isoenzymes of protein kinase C: differential involvement in apoptosis and pathogenesis. J. Clin. Pathol. Mol. Pathol. 50, 124-131.
8. Dore S., Kar S. and Quirion R. (1997) Insulin-like growth factor I protects and rescues hippocampal neurons against beta-amyloid- and human amylin-induced toxicity. Proc. Natl Acad. Sci. USA 94, 4772-4777.
9. Dore S., Takahashi M., Ferris C. D., Zakhary R., Hester L. D., Guastella D. and Snyder S. H. (1999) Bilirubin, formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury. Proc. Natl Acad. Sci. USA 96, 2445-2450.
10. Drouva S. V., Gorenne I., Laplante E., Rerat E., Enjalbert A. and Kordon C. (1990) Estradiol modulates protein kinase C activity in the rat pituitary in vivo and in vitro. Endocrinology 126, 536-544.
11. Dubal D. B., Shughrue P. J., Wilson M. E., Merchenthaler I. and Wise P. M. (1999) Estradiol modulates bcl-2 in cerebral ischemia: a potential role for estrogen receptors. J. Neurosci. 19, 6385-6393.
12. Dudek H., Datta S. R., Franke T. F., Birnbaum M. J., Yao R, Cooper G. M., Segal R. A., Kaplan D. R. and Greenberg M. E. (1997) Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 275, 661-665.
13. Fitzpatrick J. L., Mize A. L., Wade C. B., Harris J. A., Shapiro R. A. and Dorsa D. M. (2002) Estrogen-mediated neuroprotection against beta-amyloid toxicity requires expression of estrogen receptor alpha or beta and activation of the MAPK pathway. J. Neurochem. 82, 674-682.
14. Gandy S. E., Caporaso G. L., Buxbaum J. D., de Cruz Silva O., Iverfeldt K., Nordstedt C., Suzuki T., Czemik A. J., Nairn A. C. and Greengard P. (1993) Protein phosphorylation regulates relative utilization of processing pathways for Alzheimer beta/A4 amyloid precursor protein. Ann. NY Acad. Sci. 695, 117-121.
15. Garcia-Segura L. M., Cardona-Gomez P., Naftolin F. and Chowen J. A. (1998) Estradiol upregulates Bcl-2 expression in adult brain neurons. Neuroreport 9, 593-597.
16. Goodman Y., Bruce A. J., Cheng B. and Mattson M. P. (1996) Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons. J. Neurochem. 66, 1836-1844.
17. Gopalakrishna R., Chen Z. H., Gundimeda U., Wilson J. C. and Anderson W. B. (1992) Rapid filtration assays for protein kinase C activity and phorbol ester binding using multiwell plates with fitted filtration discs. Anal. Biochem. 206, 24-35.
18. Gouras G. K., Xu H., Jovanovic J. N., Buxbaum J. D., Wang R., Greengard P., Relkin N. R. and Gandy S. (1998) Generation and regulation of beta-amyloid peptide variants by neurons. J. Neurochem. 71, 1920-1925.
19. Green P. S. and Simpkins J. W. (2000) Neuroprotective effects of estrogens: potential mechanisms of action. Int. J. Dev. Neurosci. 18, 347-358.
20. Green P. S., Gridley K. E. and Simpkins J. W. (1996) Estradiol protects against beta-amyloid (25-35)-induced toxicity in SK-N-SH human neuroblastoma cells. Neurosci. Lett. 218, 165-168.
21. Gschwendt M., Dieterich S., Rennecke J., Kittstein W., Mueller H. J. and Johannes F. J. (1996) Inhibition of protein kinase C mu by various inhibitors. Differentiation from protein kinase c isoenzymes. FEBS Lett. 392, 77-80.
22. Gubina E., Rinaudo M. S., Szallasi Z., Blumberg P. M. and Mufson R. A. (1998) Overexpression of protein kinase C isoform epsilon but not delta in human interleukin-3-dependent cells suppresses apoptosis and induces bcl-2 expression. Blood 91, 823-829.
23. Henderson V. W., Paganini-Hill A., Miller B. L., Elble R. J., Reyes P. F., Shoupe D., McCleary C. A., Klein R. A., Hake A. M. and Farlow M. R. (2000) Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial. Neurology 54, 295-301.
24. Honda K., Sawada H., Kihara T., Urushitani M., Nakamizo T., Akaike A. and Shimohama S. (2000) Phosphatidylinositol 3-kinase mediates neuroprotection by estrogen in cultured cortical neurons. J. Neurosci. Res. 60, 321-327.
25. Hung A. Y., Haass C., Nitsch R. M., Qiu W. Q., Citron M., Wurtman R. J., Growdon J. H. and Selkoe D. J. (1993) Activation of protein kinase C inhibits cellular production of the amyloid beta-protein. J. Biol. Chem. 268, 22959-22962.
26. Jaffe A. B., Toran-Allerand C. D., Greengard P. and Gandy S. E. (1994) Estrogen regulates metabolism of Alzheimer amyloid beta precursor protein. J. Biol. Chem. 269, 13065-13068.
27. Jaken S. (1996) Protein kinase C isozymes and substrates. Curr. Opin. Cell Biol. 8, 168-173.
28. Kaneko Y. S., Ikeda K. and Nakanishi M. (1999) Phorbol ester inhibits DNA damage-induced apoptosis in U937 cells through activation of protein kinase C. Life Sci. 65, 2251-2258.
29. Kawas C., Resnick S., Morrison A., Brookmeyer R., Corrada M., Zonderman A., Bacal C., Lingle D. D. and Metter E. (1997) A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology 48, 1517-1521.
30. Kelly M. J. and Levin E. R. (2001) Rapid actions of plasma membrane estrogen receptors. Trends Endocrinol. Metab. 12, 152-156.
31. Kelly M. J., Lagrange A. H., Wagner E. J. and Ronnekleiv O. K. (1999) Rapid effects of estrogen to modulate G protein-coupled receptors via activation of protein kinase A and protein kinase C pathways. Steroids 64, 64-75.
32. Keshamouni V. G., Mattingly R. R. and Reddy K. B. (2002) Mechanism of 17-beta-estradiol-induced Erkl/2 activation in breast cancer cells. A role for HER2 and PKC-delta. J. Biol. Chem. 277, 22558-22565.
33. Kribben A., Wieder E. D., Li X., van Putten V., Granot Y, Schrier R. W. and Nemenoff R. A. (1993) AVP-induced activation of MAP kinase in vascular smooth muscle cells is mediated through protein kinase C. Am. J. Physiol. 265, C939-C945.
34. LeBlanc A. C., Koutroumanis M. and Goodyer C. G. (1998) Protein kinase C activation increases release of secreted amyloid precursor protein without decreasing Abeta production in human primary neuron cultures. J. Neurosci. 18, 2907-2913.
35. Lee S. J. and McEwen B. S. (2001) Neurotrophic and neuroprotective actions of estrogens and their therapeutic implications. Annu. Rev. Pharmacol. Toxicol. 41, 569-591.
36. Le Mellay V., Grosse B. and Lieberherr M. (1997) Phospholipase C beta and membrane action of calcitriol and estradiol. J. Biol. Chem. 272, 11902-11907.
37. Liu H., McPherson B. C. and Yao Z. (2001) Preconditioning attenuates apoptosis and necrosis: role of protein kinase C epsilon and -delta isoforms. Am. J. Physiol. Heart Circ. Physiol. 281, H404-H410.
38. Maher P. (2001) How protein kinase C activation protects nerve cells from oxidative stress-induced cell death. J. Neurosci. 21, 2929-2938.
39. Marino M., Pallottini V. and Trentalance A. (1998) Estrogens cause rapid activation of IP3-PKC-alpha signal transduction pathway in HEPG2 cells. Biochem. Biophys. Res. Commun. 245, 254-258.
40. Mellor H. and Parker P. J. (1998) The extended protein kinase C superfamily. Biochem. J. 332, 281-292.
41. Miller M. M., Simboli-Campbell M., Zhu X., Williamson D. G. and Franks D. J. (1994) Modulation of a renal estrogen receptor by protein kinase C. Receptors Channels 2, 33-40.
42. Mulnard R. A., Cotman C. W., Kawas C., van Dyck C. H., Sano M., Doody R., Koss E., Pfeiffer E., Jin S., Gamst A. et al. (2000) Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study. JAMA 283, 1007-1015.
43. Nishizuka Y. (1992) Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258, 607-614.
44. Paganini-Hill A. and Henderson V. W. (1996) Estrogen replacement therapy and risk of Alzheimer disease. Arch. Intern. Med. 156, 2213-2217.
45. Patrone C., Andersson S., Korhonen L. and Lindholm D. (1999) Estrogen receptor-dependent regulation of sensory neuron survival in developing dorsal root ganglion. Proc. Natl Acad. Sci. USA 96, 10905-10910.
46. Petanceska S. S. and Gandy S. (1999) The phosphatidylinositol 3-kinase inhibitor wortmannin alters the metabolism of the Alzheimer's amyloid precursor protein. J. Neurochem. 73, 2316-2320.
47. Pike C. J. (1999) Estrogen modulates neuronal Bcl-xL expression and beta-amyloid-induced apoptosis: relevance to Alzheimer's disease. J. Neurochem. 72, 1552-1563.
48. Pike C. J., Burdick D., Walencewicz A. J., Glabe C. G. and Cotman C. W. (1993) Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state. J. Neurosci. 13, 1676-1687.
49. Ruvolo P. P., Deng X., Carr, B. K. and May W. S. (1998) A functional role for mitochondrial protein kinase Calpha in Bcl2 phosphorylation and suppression of apoptosis. J. Biol. Chem. 273, 25436-25442.
50. Ruzycky A. L. and Kulick A. (1996) Estrogen increases the expression of uterine protein kinase C isozymes in a tissue specific manner. Eur J. Pharmacol. 313, 257-263.
51. Savage M. J., Trusko S. P., Howland D. S., Pinsker L. R., Mistretta S., Reaume A. G., Greenberg B. D., Siman R. and Scott R. W. (1998) Turnover of amyloid beta-protein in mouse brain and acute reduction of its level by phorbol ester. J. Neurosci. 18, 1743-1752.
52. Singer C. A., Rogers K. L. and Dorsa D. M. (1998) Modulation of Bcl-2 expression: a potential component of estrogen protection in NT2 neurons. Neuroreport 9, 2565-2568.
53. Singer C. A., Figueroa-Masot X. A., Batchelor R. H. and Dorsa D. M. (1999) The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons. J. Neurosci. 19, 2455-2463.
54. Singh M., Setalo G., Guan X., Warren M. and Toran-Allerand C. D. (1999) Estrogen-induced activation of mitogen-activated protein kinase in cerebral cortical explants: convergence of estrogen and neurotrophin signaling pathways. J. Neurosci. 19, 1179-1188.
55. Sylvia V. L., Boyan B. D., Dean D. D. and Schwartz Z. (2000) The membrane effects of 17-estradiol on chondrocyte phenotypic expression are mediated by activation of protein kinase C through phospholipase C and G-proteins. J. Steroid Biochem. Mol. Biol. 73, 211-224.
56. Sylvia V. L., Schwartz Z., Ellis E. B., Helm S. H., Gomez R., Dean D. D. and Boyan B. D. (1996) Nongenomic regulation of protein kinase C isoforms by the vitamin D metabolites 1 alpha,25-(OH) 2D3 and 24R,25-(OH) 2D3. J. Cell. Physiol. 167, 380-393.
57. Sylvia V. L., Hughes T, Dean D. D., Boyan B. D. and Schwartz Z. (1998) 17-beta-estradiol regulation of protein kinase C activity in chondrocytes is sex-dependent and involves nongenomic mechanisms. J. Cell. Physiol. 176, 435-444.
58. Szallasi Z., Smith C. B., Pettit G. R. and Blumberg P. M. (1994) Differential regulation of protein kinase C isozymes by bryostatin 1 and phorbol 12-myristate 13-acetate in NIH 3T3 fibroblasts. J. Biol. Chem. 269, 2118-2124.
59. Tang M. X., Jacobs D., Stem Y., Marder K., Schofield P., Gurland B., Andrews H. and Mayeux R. (1996) Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 348, 429-432.
60. Toran-Allerand C. D., Guan X., MacLusky N. J., Horvath T. L., Diano S., Singh M., Connolly E. S. Jr, Nethrapalli I. S. and Tinnikov A. A. (2002) ER-X: a novel, plasma membrane-associated, putative estrogen receptor that is regulated during development and after ischemic brain injury. J. Neurosci. 22, 8391-8401.
61. Toullec D., Pianetti P., Coste H., Bellevergue P., Grand-Perret T., Ajakane M., Baudet V., Boissin P., Boursier E. and Loriolle F. (1991) The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J. Biol. Chem. 266, 15771-15781.
62. Walton M., Woodgate A. M., Muravlev A., Xu R., During M. J. and Dragunow M. (1999) CREB phosphorylation promotes nerve cell survival. J. Neurochem. 73, 1836-1842.
63. Watters J. J., Campbell J. S., Cunningham M. J., Krebs E. G. and Dorsa D. M. (1997) Rapid membrane effects of steroids in neuroblastoma cells: effects of estrogen on mitogen activated protein kinase signalling cascade and c-fos immediate early gene transcription. Endocrinology 138, 4030-4033.
64. Xia Z., Dickens M., Raingeaud J., Davis R. J. and Greenberg M. E. (1995) Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270, 1326-1331.
65. Xie J., Guo Q., Zhu H., Wooten M. W. and Mattson M. P. (2000) Protein kinase C iota protects neural cells against apoptosis induced by amyloid beta-peptide. Mol. Brain Res. 82, 107-113.
66. Xu H., Gouras G. K., Greenfield J. P., Vincent B., Naslund J., Mazzarelli L., Fried G., Jovanovic J. N., Seeger M., Relkin N. R. et al. (1998) Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptides. Nat. Med. 4, 447-451.
67. Yaffe K., Sawaya G., Lieberburg I. and Grady D. (1998) Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. JAMA 279, 688-695.
68. Zhang Y., Tounekti O., Akerman B., Goodyer C. G. and LeBlanc A. (2001) 17-beta-Estradiol induces an inhibitor of active caspases. J. Neurosci. 21, 176RC.